TY  - JOUR
AU  - Platen, Moritz
AU  - Flessa, Steffen
AU  - Teipel, Stefan
AU  - Rädke, Anika
AU  - Scharf, Annelie
AU  - Mohr, Wiebke
AU  - Buchholz, Maresa
AU  - Hoffmann, Wolfgang
AU  - Michalowsky, Bernhard
TI  - Impact of low-value medications on quality of life, hospitalization and costs - A longitudinal analysis of patients living with dementia.
JO  - Alzheimer's and dementia
VL  - 19
IS  - 10
SN  - 1552-5260
CY  - Hoboken, NJ
PB  - Wiley
M1  - DZNE-2023-00670
SP  - 4520 - 4531
PY  - 2023
AB  - This study aimed to analyze the impact of low-value medications (Lvm), that is, medications unlikely to benefit patients but to cause harm, on patient-centered outcomes over 24 months.This longitudinal analysis was based on baseline, 12 and 24 months follow-up data of 352 patients with dementia. The impact of Lvm on health-related quality of life (HRQoL), hospitalizations, and health care costs were assessed using multiple panel-specific regression models.Over 24 months, 182 patients (52
KW  - Humans
KW  - Quality of Life
KW  - Health Care Costs
KW  - Hospitalization
KW  - Dementia: drug therapy
KW  - Alzheimer's disease (Other)
KW  - dementia (Other)
KW  - health care costs (Other)
KW  - health care resources (Other)
KW  - health-related quality of life (Other)
KW  - hospitalization (Other)
KW  - low-value care (Other)
LB  - PUB:(DE-HGF)16
C6  - pmid:36905286
DO  - DOI:10.1002/alz.13012
UR  - https://pub.dzne.de/record/258697
ER  -